Pawan Bir Kohli
Genentech · 29 works · 2,620 citations · h-index 19
Top works
- Sensitivity to antitubulin chemotherapeutics is regulated by MCL1 and FBW7
- Discovery of GDC-0853: A Potent, Selective, and Noncovalent Bruton’s Tyrosine Kinase Inhibitor in Early Clinical Development
- Structure of the pseudokinase–kinase domains from protein kinase TYK2 reveals a mechanism for Janus kinase (JAK) autoinhibition
- A Restricted Role for TYK2 Catalytic Activity in Human Cytokine Responses Revealed by Novel TYK2-Selective Inhibitors
- Lead Optimization of a 4-Aminopyridine Benzamide Scaffold To Identify Potent, Selective, and Orally Bioavailable TYK2 Inhibitors
- Lead identification of novel and selective TYK2 inhibitors
- Identification of Imidazo-Pyrrolopyridines as Novel and Potent JAK1 Inhibitors
- Battling Btk Mutants With Noncovalent Inhibitors That Overcome Cys481 and Thr474 Mutations
- NF-κB inducing kinase is a therapeutic target for systemic lupus erythematosus
- RIP1 inhibition blocks inflammatory diseases but not tumor growth or metastases
- Identification of C-2 Hydroxyethyl Imidazopyrrolopyridines as Potent JAK1 Inhibitors with Favorable Physicochemical Properties and High Selectivity over JAK2
- Discovery and Optimization of C-2 Methyl Imidazopyrrolopyridines as Potent and Orally Bioavailable JAK1 Inhibitors with Selectivity over JAK2
- Structure-Based Design of Tricyclic NF-κB Inducing Kinase (NIK) Inhibitors That Have High Selectivity over Phosphoinositide-3-kinase (PI3K)
- A Non-covalent Ligand Reveals Biased Agonism of the TRPA1 Ion Channel
- Discovery of a class of highly potent Janus Kinase 1/2 (JAK1/2) inhibitors demonstrating effective cell-based blockade of IL-13 signaling
- Lung-restricted inhibition of Janus kinase 1 is effective in rodent models of asthma
- Structure-based discovery of C-2 substituted imidazo-pyrrolopyridine JAK1 inhibitors with improved selectivity over JAK2
- Novel triazolo-pyrrolopyridines as inhibitors of Janus kinase 1
- Potent and selective inhibitors of receptor-interacting protein kinase 1 that lack an aromatic back pocket group
- Identification of an imidazopyridine scaffold to generate potent and selective TYK2 inhibitors that demonstrate activity in an in vivo psoriasis model